Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 29, 2026
Impact of Bridging Response on Outcomes after CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 13, 2026
Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.
Journal: Transplantation and cellular therapy
Published: March 04, 2026
Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignancies.
Journal: Transplantation and cellular therapy
Published: March 04, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations.
Journal: Transplantation and cellular therapy
Published: January 20, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Blood cancer discovery
Published: January 04, 2026
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma.
Journal: Blood
Published: September 03, 2025
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: September 03, 2025
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: September 03, 2025
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.
Journal: Blood
Published: September 03, 2025
Last Updated: 09/26/2026